A new Mayo Clinic analysis of more than 250,000 health records reveals that GLP-1 drugs could outperform metformin in reversing prediabetes and lowering heart risks.
Inc.com
A Massive Study of 250,000 Patients Just Revealed a Surprising New Use for GLP-1s
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.